Concepedia
Statistics
Publications
39
Citations
2.3K
H-Index
26
Active since
1985
Affiliations
Pfizer (United States)(Current)
Rapt Therapeutics (United States)
APT Therapeutics (United States)
Gaertner (United States)
Aptose Biosciences (United States)
David J. Wustrow is an author at Pfizer (United States) specializing in pharmacology, medicine, and medicinal chemistry.
Publications per year
1985–2023
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis
Daniel J. Anderson, Ronan Le Moigne, Stevan Djakovic et al. · Cancer Cell · 2015 · 401 citations · Full text
Life Sciences, Molecular Biology, Oncology +8
Isoindolinone enantiomers having affinity for the dopamine D4 receptor
Thomas R. Belliotti, Wouter A. Brink, Suzanne R. Kesten et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 213 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +11
Structure−Activity Relationships of Pregabalin and Analogues That Target the α<sub>2</sub>-δ Protein
Thomas R. Belliotti, Thomas Capiris, I. Victor Ekhato et al. · Journal of Medicinal Chemistry · 2005 · 210 citations
Medicine, Medicinal Chemistry, Pharmacology +17
Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083)
Han-Jie Zhou, Jinhai Wang, Bing Yao et al. · Journal of Medicinal Chemistry · 2015 · 193 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +17
Tumors establish resistance to immunotherapy by regulating T<sub>reg</sub>recruitment via CCR4
Lisa A. Marshall, Sachie Marubayashi, Aparna Jorapur et al. · Journal for ImmunoTherapy of Cancer · 2020 · 144 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 39